Dr. Narendrakumar Alappan, MD

Dr. Alappan practices at Fairview Hospital in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Dr. Alappan's NPI, 1265713911, was assigned on September 7, 2011. Dr. Alappan holds Ohio license 120883.

Dr. Alappan's primary practice is Fairview Hospital, at 18101 Lorain Avenue, Cleveland, OH 44111 in Cuyahoga County. The practice phone is (216) 476-7000.

Dr. Alappan's primary practice is Fairview Hospital in Cleveland, Ohio, part of The Cleveland Clinic Foundation. Dr. Alappan is also affiliated with Cleveland Clinic Main Campus. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Alappan to 1 more hospital, 1 hospice and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alappan practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Alappan's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Alappan is licensed in Ohio.

CMS data shows 488 Medicare services from Dr. Alappan across 7 procedure codes in 2024, for 260 Medicare patients. Medicare paid $37,068 for them.

CMS counts 260 Medicare patients who saw Dr. Alappan in 2024. The largest group is 65 to 74, with 112 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.38, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alappan's median patient age at 68, with 50% women.

In 2017, Dr. Alappan wrote 204 Medicare Part D claims. They cover 10 drugs, with $58,255 in total drug cost. In 2016, CMS named 371 claims across 14 drugs.

Dr. Alappan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 13 papers to Dr. Alappan, published from 2013 to 2019. 2013 was the busiest year, with 5. The most frequent topics are Echocardiography, Foramen Ovale, Patent and Hypoxia. Dr. Alappan has published most often in Chest. Dr. Alappan's most frequent co-authors are Achuta Kumar Guddati, MD, Amit Chopra, MD and Ajit Rajeshwar Moghekar, MBBS.

Dmand AI links Dr. Alappan to 2 clinical trials, 2 of them phase 2 studies. Conditions studied include COVID-19 and Pneumonia, Viral. The Cleveland Clinic sponsors the most, 2.

CMS Open Payments shows 14 general payments to Dr. Alappan from 9 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 95% of the total. United Therapeutics Corporation paid the most, $100.